首页> 外文期刊>Journal of Clinical Pathology >Involvement of MMP-7 in invasion of pancreatic cancer cells through activation of the EGFR mediated MEK-ERK signal transduction pathway
【24h】

Involvement of MMP-7 in invasion of pancreatic cancer cells through activation of the EGFR mediated MEK-ERK signal transduction pathway

机译:MMP-7通过激活EGFR介导的MEK-ERK信号转导通路参与胰腺癌细胞的侵袭

获取原文
获取原文并翻译 | 示例
           

摘要

Aims: To clarify the involvement of matrix metalloproteinase-7 (MMP-7) in cell dissociation and the subsequent invasion of pancreatic cancer cells. Methods: Western blotting, in vitro invasion assay, immunocytochemistry, and immunohistochemistry were performed in pancreatic cancer cell lines or pancreatic cancer tissue. Results: The active form of the MMP-7 protein was expressed exclusively in the conditioned medium of dissociated (PC-1.0 and AsPC-1) pancreatic cancer cells, whereas proMMP-7 protein was only detected in the conditioned medium of non-dissociated (PC-1 and Capan-2) cells. Both intracellular and conditioned medium localised MMP-7 was greatly reduced by treatment with the epidermal growth factor receptor (EGFR) inhibitor AG1478 and the mitogen activated protein kinase kinase (MEK) inhibitor U0126 in pancreatic cancer cells. MMP-7 treatment significantly induced the disruption of tight junction (TJ) structures and subsequent cell dissociation, and activation of the EGFR mediated MEK- ERK (extracellular signal regulated protein kinase) signalling pathway in the non-dissociated pancreatic cancer cells. Moreover, the strong in vitro invasiveness of dissociated cells was inhibited by AG1478 and U0126 treatment, whereas the weak invasiveness of non-dissociated cells was apparently induced by MMP-7 treatment. In addition, MMP-7 expression was stronger at the invasive front than at the centre of human pancreatic tumours. Conclusion: MMP-7 is involved in cell dissociation and the subsequent invasion of pancreatic cancer cells. It induces the disruption of TJ structures and forms a positive feedback loop with activation of the EGFR mediated MEK-ERK signalling pathway.
机译:目的:阐明基质金属蛋白酶-7(MMP-7)参与细胞解离和随后侵袭胰腺癌细胞的作用。方法:在胰腺癌细胞系或胰腺癌组织中进行蛋白质印迹,体外侵袭测定,免疫细胞化学和免疫组织化学。结果:MMP-7蛋白的活性形式仅在离解的胰腺癌细胞(PC-1.0和AsPC-1)的条件培养基中表达,而proMMP-7蛋白仅在未离解的胰腺癌细胞的条件培养基中表达。 PC-1和Capan-2)细胞。通过在胰腺癌细胞中使用表皮生长因子受体(EGFR)抑制剂AG1478和有丝分裂原活化蛋白激酶激酶(MEK)抑制剂U0126治疗,细胞内和条件培养基中定位的MMP-7均大大降低。 MMP-7治疗显着诱导了未分离的胰腺癌细胞中紧密连接(TJ)结构的破坏和随后的细胞解离,以及EGFR介导的MEK- ERK(细胞外信号调节蛋白激酶)信号通路的激活。此外,AG1478和U0126处理抑制了离体细胞的强体外侵袭性,而MMP-7处理显然诱导了非离体细胞的弱侵袭性。另外,MMP-7在侵袭性前端的表达强于人类胰腺肿瘤的中心。结论:MMP-7参与了胰腺癌细胞的解离和随后的侵袭。它诱导TJ结构的破坏,并通过激活EGFR介导的MEK-ERK信号通路形成正反馈环。

著录项

  • 来源
    《Journal of Clinical Pathology》 |2005年第12期|p.1242-1248|共7页
  • 作者单位

    Department of Gastroenterological Surgery, Graduate School of Medical Sciences, Kumamoto University, Honjo 1-1-1, Kumamoto 860-8556, Japan;

  • 收录信息 美国《科学引文索引》(SCI);美国《化学文摘》(CA);
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类 病理学;
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号